Valeria D’Ovidio 1, Donatella Meo, Angelo Viscido, Giampaolo Bresci, Piero Vernia, Renzo Caprilli, World J Gastroenterol. 2011 Apr 14;17(14):1831-5.
Tag: Long-term efficacy
Scientific corner
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis
GMA may be a valid therapeutic option for steroid-dependent ulcerative colitis patients with mild-moderate disease and its clinical efficacy seems to persist for 12 months.
Scientific corner
13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis – the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan
Contact UsFor more information
Contact Us